A 60-day trial in India found that taking nicotinamide mononucleotide (NMN) at 600mg per day is the optimal dose for boosting the body’s nicotinamide adenine dinucleotide (NAD+) level and physical performance.
NMN, an anti-aging ingredient, has been disallowed by FDA because of its prior investigation as a drug. The determination, which came as something of a surprise given the ingredient’s market history, has raised questions of fairness and transparency.
This round-up of new scientific findings will look at how low NAD+ level is associated with anaemia in women, Mitsubishi Life Sciences’ NMN clinical study findings, and the benefits of vitamin E for exercise recovery and PCOS.
Supplements that claim to boost the body’s level of nicotinamide adenine dinucleotide (NAD+), namely nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR), are increasingly common in Asia’s dietary supplement market.
Next Miracle Nutrient is opening its first retail outlet in Hong Kong selling its nicotinamide mononucleotide (NMN) supplement, with the firm also hoping it will serve as an ‘experience centre’ to educate the public on NMN.